Brookfield (BAM) Q3 2026 Earnings Call Transcript

Brookfield Asset Management reported Q3 fee-related earnings of $864 million ($0.54 per share) and distributable earnings of $763 million ($0.47 per share), each up 15% year over year; fee-bearing capital rose 13% to $682 billion. Fundraising totaled $123 billion through the first nine months of 2026, including $50 billion raised or committed for infrastructure over the past year, while management said 2026 earnings would be modestly below its initial targets because infrastructure fees begin January 1, 2027, and a BBU performance fee is not expected this year. Brookfield also cited AI infrastructure projects in South Korea and the U.K., and targeted more than $2 billion in annual net carried-interest realizations starting in 2032; the board declared a $0.25 quarterly dividend.

Analysis

The key distinction is between capital raised and earnings actually accruing: $68B of commitments are not yet fee-paying, and the infrastructure flagship’s fee start is deferred to Jan. 1. That creates a visible 2027 FRE catalyst, but also means current fundraising headlines overstate near-term monetization. The $680M annual revenue estimate depends on deployment pace and fee terms; track fee-bearing capital conversion, not commitments alone.

BAM’s growth mix is improving in durability, but the carry narrative is easy to overcapitalize. Near-term realizations are episodic; the larger figures are conditional on fund performance and monetizations years out. Likewise, Westinghouse’s cited gross IRR is not evidence of equivalent shareholder cash returns. The Oaktree integration broadens credit distribution and could create operating leverage, while also lowering the reported margin through mix; monitor FRE dollars and incremental expense, not margin in isolation.

AI infrastructure is an execution-and-credit-underwriting opportunity, not simply a demand trade. Contracted offtake reduces merchant exposure but does not remove counterparty, construction, power-delivery, equipment, or contract-enforcement risk. Scarce execution capacity may support returns for capable developers, while delays can defer fee income and tie up capital. Drax’s project remains potential scale, not realized investment economics; NVDA’s participation is not proof of BAM project profitability. A second-order risk: 85% recommitment at mature strategies supports retention today but concentrates fundraising resilience in existing LP allocation decisions.

Near term, the modest 2026 outlook and delayed fees can cap the reaction to strong fundraising. Over 1–3 months, final fund close and Q4 fee/carry conversion matter; over 6–18 months, fee activation and deployment are the proof points. No valuation data are supplied, so avoid chasing on operating momentum alone.

Key Decisions for Investors

• BAM: Prefer staged entry on weakness rather than buying the fundraising narrative outright. Reassess after the flagship fee switch-on and Q1 fee-bearing-capital disclosure; upside depends on commitments converting into fee revenue, while the main downside is continued deployment/timing slippage.
• Track three falsifiers: fee-bearing capital failing to step up after Jan. 1, FRE growth decelerating despite deployment, or expenses rising enough to prevent the promised Oaktree operating leverage. These would weaken the recurring-earnings thesis.
• Treat AI infrastructure exposure as a diligence watch item, not a standalone long: verify executed offtake/backstop terms, permits, equipment availability, power delivery, and construction milestones for the Korea and UK projects. Counterparty deterioration or schedule slippage would challenge the de-risking claim.
• Do not underwrite BAM on the $2B-plus annual carry outlook today. Treat carry as optionality until audited realized distributions establish a repeatable cadence; the near-term carry contribution is explicitly episodic.
• BN may receive royalty economics on post-spinout BAM carry, but the supplied data do not establish enough relative valuation or ownership detail for a BAM/BN pair. Avoid a relative-value position without verifying the royalty base, terms, and current pricing.